Price T Rowe Associates Inc. MD Purchases 343,915 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Price T Rowe Associates Inc. MD grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,266,781 shares of the medical instruments supplier’s stock after buying an additional 343,915 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 3.02% of DENTSPLY SIRONA worth $207,995,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Magnetar Financial LLC bought a new stake in DENTSPLY SIRONA during the 1st quarter worth approximately $2,668,000. Lazard Asset Management LLC grew its holdings in shares of DENTSPLY SIRONA by 3.2% during the first quarter. Lazard Asset Management LLC now owns 4,080,795 shares of the medical instruments supplier’s stock worth $135,440,000 after purchasing an additional 126,351 shares during the last quarter. Gabelli Funds LLC increased its stake in shares of DENTSPLY SIRONA by 0.4% in the first quarter. Gabelli Funds LLC now owns 217,000 shares of the medical instruments supplier’s stock valued at $7,202,000 after buying an additional 800 shares in the last quarter. Toronto Dominion Bank increased its stake in shares of DENTSPLY SIRONA by 11.0% in the first quarter. Toronto Dominion Bank now owns 99,358 shares of the medical instruments supplier’s stock valued at $3,298,000 after buying an additional 9,824 shares in the last quarter. Finally, Advisors Asset Management Inc. lifted its position in DENTSPLY SIRONA by 99.3% during the 1st quarter. Advisors Asset Management Inc. now owns 14,548 shares of the medical instruments supplier’s stock worth $483,000 after buying an additional 7,248 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on XRAY. Needham & Company LLC lowered their price objective on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a research report on Friday, May 3rd. Stifel Nicolaus lowered their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. The Goldman Sachs Group reduced their price objective on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday, May 6th. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Finally, StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $33.67.

DENTSPLY SIRONA Trading Down 0.1 %

Shares of NASDAQ XRAY traded down $0.02 during midday trading on Friday, reaching $26.41. 1,748,732 shares of the stock were exchanged, compared to its average volume of 2,495,531. The company has a market capitalization of $5.48 billion, a price-to-earnings ratio of -60.02, a P/E/G ratio of 1.18 and a beta of 1.01. DENTSPLY SIRONA Inc. has a 12 month low of $23.94 and a 12 month high of $41.65. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. The business has a 50-day simple moving average of $26.32 and a two-hundred day simple moving average of $30.34.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.42. The firm had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company’s revenue was down 2.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.39 EPS. As a group, equities research analysts expect that DENTSPLY SIRONA Inc. will post 2.02 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Friday, June 28th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.42%. The ex-dividend date of this dividend was Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier purchased 3,577 shares of the company’s stock in a transaction that occurred on Friday, May 31st. The stock was acquired at an average cost of $27.95 per share, with a total value of $99,977.15. Following the acquisition, the director now owns 58,374 shares in the company, valued at approximately $1,631,553.30. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.52% of the stock is owned by company insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.